99 related articles for article (PubMed ID: 7891281)
1. Drug release from a suspension with a finite dissolution rate: theory and its application to a betamethasone 17-valerate patch.
Kubota K; Twizell EH; Maibach HI
J Pharm Sci; 1994 Nov; 83(11):1593-9. PubMed ID: 7891281
[TBL] [Abstract][Full Text] [Related]
2. Release of drugs from ointment bases II: In vitro release of benzocaine from suspension-type aqueous gels.
Bottari F; Di Colo G; Nannipieri E; Saettone MF; Serafini MF
J Pharm Sci; 1977 Jul; 66(7):926-31. PubMed ID: 886452
[TBL] [Abstract][Full Text] [Related]
3. Characterization of silicone pressure-sensitive adhesive episcleral implant for drug delivery.
Wen H; Li SK
Drug Dev Ind Pharm; 2016 Jan; 42(1):107-115. PubMed ID: 25923417
[TBL] [Abstract][Full Text] [Related]
4. Diffusion model for drug release from suspensions II: release to a perfect sink.
Lindstrom FT; Ayres JW
J Pharm Sci; 1977 May; 66(5):662-8. PubMed ID: 874747
[TBL] [Abstract][Full Text] [Related]
5. Assessment of drug salt release from solutions, suspensions and in situ suspensions using a rotating dialysis cell.
Parshad H; Frydenvang K; Liljefors T; Cornett C; Larsen C
Eur J Pharm Sci; 2003 Jul; 19(4):263-72. PubMed ID: 12885391
[TBL] [Abstract][Full Text] [Related]
6. Effect of dimethylpolysiloxane fluid on the stability and dissolution of prednisolone.
Asker AF; Whitworth CW
Pharmazie; 1976 Apr; 31(4):240-1. PubMed ID: 935226
[TBL] [Abstract][Full Text] [Related]
7. Dissolution profiles for finely divided drug suspensions.
Mauger JW; Howard SA; Amin K
J Pharm Sci; 1983 Feb; 72(2):190-3. PubMed ID: 6834260
[TBL] [Abstract][Full Text] [Related]
8. Estimation of dissolution rate of salicylamide in complexing media using a theoretical diffusion model.
Donbrow M; Touitou E
J Pharm Sci; 1978 Jan; 67(1):95-8. PubMed ID: 619122
[TBL] [Abstract][Full Text] [Related]
9. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
Roy SD; Gutierrez M; Flynn GL; Cleary GW
J Pharm Sci; 1996 May; 85(5):491-5. PubMed ID: 8742940
[TBL] [Abstract][Full Text] [Related]
10. Diffusion model for drug release from suspensions I: theoretical considerations.
Ayres JW; Lindstrom FT
J Pharm Sci; 1977 May; 66(5):654-62. PubMed ID: 874746
[TBL] [Abstract][Full Text] [Related]
11. Comparison and analysis of theoretical models for diffusion-controlled dissolution.
Wang Y; Abrahamsson B; Lindfors L; Brasseur JG
Mol Pharm; 2012 May; 9(5):1052-66. PubMed ID: 22384832
[TBL] [Abstract][Full Text] [Related]
12. The mean dissolution time depends on the dose/solubility ratio.
Rinaki E; Dokoumetzidis A; Macheras P
Pharm Res; 2003 Mar; 20(3):406-8. PubMed ID: 12669960
[TBL] [Abstract][Full Text] [Related]
13. Numerical modelling and experimental investigation of drug release from layered silicone matrix systems.
Snorradóttir BS; Jónsdóttir F; Sigurdsson ST; Thorsteinsson F; Másson M
Eur J Pharm Sci; 2013 Jul; 49(4):671-8. PubMed ID: 23684932
[TBL] [Abstract][Full Text] [Related]
14. Drug Release from a Spherical Matrix: Theoretical Analysis for a Finite Dissolution Rate Affected by Geometric Shape of Dispersed Drugs.
Lin YS; Tsay RY
Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32585967
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous diffusion and metabolism of betamethasone 17-valerate in the living skin equivalent.
Kubota K; Ademola J; Maibach HI
J Pharm Sci; 1995 Dec; 84(12):1478-81. PubMed ID: 8748331
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the dissolution behavior of zinc-complexed protein suspensions by computer modeling and simulation.
Prabhu S; Jacknowitz AI; Stout PJ
Drug Dev Ind Pharm; 2002 Jul; 28(6):703-9. PubMed ID: 12149963
[TBL] [Abstract][Full Text] [Related]
17. Mathematical model to analyze the dissolution behavior of metastable crystals or amorphous drug accompanied with a solid-liquid interface reaction.
Hirai D; Iwao Y; Kimura SI; Noguchi S; Itai S
Int J Pharm; 2017 Apr; 522(1-2):58-65. PubMed ID: 28235625
[TBL] [Abstract][Full Text] [Related]
18. Tissue distribution of dexamethasone in feline ocular structures following single topical application of dexamethasone as an ointment or suspension.
Bessonova J; Meyer-Lindenberg A; Bäumer W; Kietzmann M
Vet Ophthalmol; 2011 Mar; 14(2):109-13. PubMed ID: 21366826
[TBL] [Abstract][Full Text] [Related]
19. Formulation and comparative in vitro evaluation of various dexamethasone-loaded pH-sensitive polymeric nanoparticles intended for dermal applications.
Sahle FF; Gerecke C; Kleuser B; Bodmeier R
Int J Pharm; 2017 Jan; 516(1-2):21-31. PubMed ID: 27845215
[TBL] [Abstract][Full Text] [Related]
20. Release rates from topical formulations containing drugs in suspension.
Bunge AL
J Control Release; 1998 Mar; 52(1-2):141-8. PubMed ID: 9685944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
